Furthermore, KIAA1324 has been reported to counteract insulin signaling by interacting with insulin receptor (INSR) and insulin-like growth factor 1 receptor (IGF1R) and inhibit cell proliferation, supporting the tumor-suppressive role of KIAA1324 [18]. The gene discussed is ELAPOR1; the disease is neoplasm.